written on 17.04.2014
Tags:
,

GlaxoSmithKline steps up bribery probes, eyeing potential violations in 9 Middle Eastern countries

TAGS: ,

GlaxoSmithKline has added two more countries to its bribery-investigation list. The U.K.-based drugmaker now says it faces probes in Jordan and Lebanon, in addition to recently announced investigations in Iraq and Poland.

Latest Report